136 related articles for article (PubMed ID: 35715935)
1. Technical note: Optimal allocation of limited proton therapy resources using model-based patient selection.
Papp D; Unkelbach J
Med Phys; 2022 Aug; 49(8):4980-4987. PubMed ID: 35715935
[TBL] [Abstract][Full Text] [Related]
2. Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy.
Loizeau N; Fabiano S; Papp D; Stützer K; Jakobi A; Bandurska-Luque A; Troost EGC; Richter C; Unkelbach J
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):196-207. PubMed ID: 33848609
[TBL] [Abstract][Full Text] [Related]
3. Patient selection for proton therapy using Normal Tissue Complication Probability with deep learning dose prediction for oropharyngeal cancer.
Huet-Dastarac M; Michiels S; Rivas ST; Ozan H; Sterpin E; Lee JA; Barragan-Montero A
Med Phys; 2023 Oct; 50(10):6201-6214. PubMed ID: 37140481
[TBL] [Abstract][Full Text] [Related]
4. Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy.
Bijman RG; Breedveld S; Arts T; Astreinidou E; de Jong MA; Granton PV; Petit SF; Hoogeman MS
Acta Oncol; 2017 Nov; 56(11):1444-1450. PubMed ID: 28828923
[TBL] [Abstract][Full Text] [Related]
5. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
[TBL] [Abstract][Full Text] [Related]
6. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an automated clinical decision system with deep learning dose prediction and NTCP model for prostate cancer proton therapy.
Chen M; Pang B; Zeng Y; Xu C; Chen J; Yang K; Chang Y; Yang Z
Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38718814
[No Abstract] [Full Text] [Related]
8. Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial.
McNamara AL; Hall DC; Shusharina N; Liu A; Wei X; Ajdari A; Mohan R; Liao Z; Paganetti H
Radiother Oncol; 2020 Jun; 147():8-14. PubMed ID: 32224318
[TBL] [Abstract][Full Text] [Related]
9. Proton Therapy in Breast Cancer: A Review of Potential Approaches for Patient Selection.
Wu XY; Chen M; Cao L; Li M; Chen JY
Technol Cancer Res Treat; 2024; 23():15330338241234788. PubMed ID: 38389426
[TBL] [Abstract][Full Text] [Related]
10. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
[TBL] [Abstract][Full Text] [Related]
11. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
12. Inter- and intrafractional 4D dose accumulation for evaluating ΔNTCP robustness in lung cancer.
Smolders A; Hengeveld AC; Both S; Wijsman R; Langendijk JA; Weber DC; Lomax AJ; Albertini F; Guterres Marmitt G
Radiother Oncol; 2023 May; 182():109488. PubMed ID: 36706960
[TBL] [Abstract][Full Text] [Related]
13. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
[TBL] [Abstract][Full Text] [Related]
14. Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
Pedersen J; Flampouri S; Bryant C; Liang X; Mendenhall N; Li Z; Liu M; Muren LP
Radiother Oncol; 2020 Jan; 142():253-260. PubMed ID: 31630864
[TBL] [Abstract][Full Text] [Related]
15. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
[TBL] [Abstract][Full Text] [Related]
16. First experience with model-based selection of head and neck cancer patients for proton therapy.
Tambas M; Steenbakkers RJHM; van der Laan HP; Wolters AM; Kierkels RGJ; Scandurra D; Korevaar EW; Oldehinkel E; van Zon-Meijer TWH; Both S; van den Hoek JGM; Langendijk JA
Radiother Oncol; 2020 Oct; 151():206-213. PubMed ID: 32768508
[TBL] [Abstract][Full Text] [Related]
17. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
18. Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
Dutz A; Lühr A; Troost EGC; Agolli L; Bütof R; Valentini C; Baumann M; Vermeren X; Geismar D; Timmermann B; Krause M; Löck S
Radiother Oncol; 2021 Jul; 160():69-77. PubMed ID: 33872640
[TBL] [Abstract][Full Text] [Related]
19. Combined proton-photon therapy for non-small cell lung cancer.
Amstutz F; Fabiano S; Marc L; Weber DC; Lomax AJ; Unkelbach J; Zhang Y
Med Phys; 2022 Aug; 49(8):5374-5386. PubMed ID: 35561077
[TBL] [Abstract][Full Text] [Related]
20. The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.
Widder J; van der Schaaf A; Lambin P; Marijnen CAM; Pignol JP; Rasch CR; Slotman BJ; Verheij M; Langendijk JA
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):30-36. PubMed ID: 26684410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
